Validity of Remission Criteria in Rheumatoid Arthritis Compared to Ultrasound-Defined Remission
- PMID: 36407714
- PMCID: PMC9645519
- DOI: 10.18295/squmj.9.2021.128
Validity of Remission Criteria in Rheumatoid Arthritis Compared to Ultrasound-Defined Remission
Abstract
Objectives: Remission is the ultimate purpose of treatment in rheumatoid arthritis (RA). However, even when the most stringent composite scores are used, structural damages can occur; hence, ultrasonography (US) appears to be the best way to assess real remission. This study aimed to investigate the validity of different RA remission scores using US as a reference.
Methods: An analytic diagnostic study, of 30 RA patients in remission (according to the Disease Activity Score in 28 Joints [DAS28]) and a control group with active RA, was conducted between January and October 2018 at Mongi Slim Hospital in Tunis, Tunisia. Among them, patients in remission were identified according to their Simple Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI) and the Boolean American College of Rheumatology/European League against Rheumatism activity index (ACR/EULAR) remission scores. The validity of each activity score for remission was calculated by considering the absence of power Doppler (PD) signals as a gold standard.
Results: All patients were in remission according to the DAS28, with an average score of 2.03 (1.1-2.6). US examination showed PD signals in 57% of patients. A total of 26 patients were in remission according to the CDAI; a Doppler signal was detected in 58% of those cases. SDAI remission was accomplished in 19 patients, with PD activity in 53% of cases. Of the 14 patients in remission according to the Boolean ACR/EULAR criteria, synovial hyper-vascularisation was found in 64%. Considering true remission as the absence of PD signals, the most sensitive and specific score was the DAS28 (93% and 68%, respectively).
Conclusion: Considering remission in RA as the absence of vascularised synovitis, the DAS28 is the most sensitive and most specific score.
Keywords: Doppler; Reproducibility of Results; Rheumatoid Arthritis; Tunisia; Ultrasonography.
© Copyright 2022, Sultan Qaboos University Medical Journal, All Rights Reserved.
Conflict of interest statement
CONFLICT OF INTEREST The authors declare no conflicts of interest.
Figures
Similar articles
-
ACR/EULAR Definitions of Remission Are Associated with Lower Residual Inflammatory Activity Compared with DAS28 Remission on Hand MRI in Rheumatoid Arthritis.J Rheumatol. 2016 Sep;43(9):1631-6. doi: 10.3899/jrheum.150849. Epub 2016 Jul 1. J Rheumatol. 2016. PMID: 27370881
-
In patients with early rheumatoid arthritis, the new ACR/EULAR definition of remission identifies patients with persistent absence of functional disability and suppression of ultrasonographic synovitis.Ann Rheum Dis. 2013 Feb;72(2):245-9. doi: 10.1136/annrheumdis-2012-201817. Epub 2012 Oct 11. Ann Rheum Dis. 2013. PMID: 23060009
-
Comparable long-term outcomes between DAS28-ESR remission criteria and ACR/EULAR definitions in patients with established rheumatoid arthritis.Clin Rheumatol. 2021 Jul;40(7):2665-2672. doi: 10.1007/s10067-021-05603-z. Epub 2021 Jan 27. Clin Rheumatol. 2021. PMID: 33506371
-
Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease.Ann Rheum Dis. 2016 Jul;75(7):1268-71. doi: 10.1136/annrheumdis-2016-209429. Epub 2016 Apr 1. Ann Rheum Dis. 2016. PMID: 27037326 Free PMC article. Review.
-
After treat-to-target: can a targeted ultrasound initiative improve RA outcomes?Ann Rheum Dis. 2012 Jun;71(6):799-803. doi: 10.1136/annrheumdis-2011-201048. Epub 2012 May 5. Ann Rheum Dis. 2012. PMID: 22562979 Review.
Cited by
-
The Role of Musculoskeletal Ultrasound in Biologic Drug Tapering and Relapse Monitoring: Findings from a One-Year Prospective Study in a Cohort of Rheumatoid Arthritis Patients in Sustained Clinical Remission.Diagnostics (Basel). 2025 Jul 10;15(14):1753. doi: 10.3390/diagnostics15141753. Diagnostics (Basel). 2025. PMID: 40722503 Free PMC article.
-
MMP-13, VEGF, and Disease Activity in a Cohort of Rheumatoid Arthritis Patients.Diagnostics (Basel). 2023 May 8;13(9):1653. doi: 10.3390/diagnostics13091653. Diagnostics (Basel). 2023. PMID: 37175043 Free PMC article.
-
Clinical and Ultrasonographic Remission in Bio-naïve and Bio-failure Patients with Rheumatoid Arthritis at 24 Weeks of Upadacitinib Treatment: The UPARAREMUS Real-Life Study.Rheumatol Ther. 2024 Oct;11(5):1347-1361. doi: 10.1007/s40744-024-00712-y. Epub 2024 Aug 23. Rheumatol Ther. 2024. PMID: 39177745 Free PMC article.
References
-
- Paulshus Sundlisæter N, Olsen IC, Aga AB, Hammer HB, Uhlig T, van der Heijde D, et al. Predictors of sustained remission in patients with early rheumatoid arthritis treated according to an aggressive treat-to-target protocol. Rheumatology (Oxford) 2018;57:2022–31. doi: 10.1093/rheumatology/key202. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials